完整後設資料紀錄
DC 欄位語言
dc.contributor.authorLee, Meng-Shiueen_US
dc.contributor.authorYao, Da-Jengen_US
dc.contributor.authorHsu, Wensyangen_US
dc.date.accessioned2015-07-21T08:28:49Z-
dc.date.available2015-07-21T08:28:49Z-
dc.date.issued2015-01-01en_US
dc.identifier.issn1568-0266en_US
dc.identifier.urihttp://hdl.handle.net/11536/124862-
dc.description.abstractAn implantable system for drug delivery provides a new strategy for drug therapy, and typically involves a microfluidic chip produced with micro or nano-technology. Implantable systems have the flexibility to conform various schemes of drug release, including zero order, pulsatile, and on demand dosing, as opposed to a standard sustained release profile. Such an implantable system is classified as allowing either controllable or uncontrollable drug release after implantation, so an active or passive delivery system respectively. The performance and related applications of these systems vary. The key points of each technology are highlighted such as performance, working principle, fabrication methods, and dimensional constrains. We here review the implantable drug-delivery system in current research with a focus on application and chip performance, and comparison for passive and active delivery system.en_US
dc.language.isoen_USen_US
dc.subjectDrug deliveryen_US
dc.subjectImplanten_US
dc.subjectMEMSen_US
dc.subjectMicrofluidicen_US
dc.titleAn Implantable Drug-delivery System on a Chipen_US
dc.typeReviewen_US
dc.identifier.journalCURRENT TOPICS IN MEDICINAL CHEMISTRYen_US
dc.citation.volume15en_US
dc.citation.issue15en_US
dc.citation.spage1516en_US
dc.citation.epage1524en_US
dc.contributor.department機械工程學系zh_TW
dc.contributor.departmentDepartment of Mechanical Engineeringen_US
dc.identifier.wosnumberWOS:000355196100005en_US
dc.citation.woscount0en_US
顯示於類別:期刊論文